Multidrug-resistant Neisseria gonorrhoeae isolate SE690: mosaic penA-60.001 gene causing ceftriaxone resistance internationally has spread to the more antimicrobial-susceptible genomic lineage, Sweden, September 2022
Daniel Golparian, Nora Vestberg, Wiktor Södersten, Susanne Jacobsson, Makoto Ohnishi, Hong Fang, Karin Haij Bhattarai, Magnus Unemo
Abstract
We report a ceftriaxone-resistant, multidrug-resistant urogenital Neisseria gonorrhoeae in a female sex worker in Sweden, September 2022, who was treated with ceftriaxone 1 g, but did not return for test-of-cure. Whole genome sequencing of isolate SE690 identified MLST ST8130, NG-STAR CC1885 (new NG-STAR ST4859) and mosaic penA-60.001 . The latter, causing ceftriaxone resistance in the internationally spreading FC428 clone, has now also spread to the more antimicrobial-susceptible genomic lineage B, showing that strains across the gonococcal phylogeny can develop ceftriaxone resistance.
Topics & Concepts
CeftriaxoneNeisseria gonorrhoeaeBiologyAntibiotic resistanceMultiple drug resistanceMicrobiologyLineage (genetic)AntimicrobialDrug resistanceVirologyGeneAntibioticsGeneticsReproductive tract infections researchSyphilis Diagnosis and TreatmentBacterial Infections and Vaccines